TY - JOUR
T1 - Development of Isoselenocyanate Compounds' Syntheses and Biological Applications
AU - Frieben, Emily E.
AU - Amin, Shantu
AU - Sharma, Arun K.
N1 - Funding Information:
We thank the Department of Pharmacology, Penn State College of Medicine, and Penn State Cancer Institute for the financial support.
Publisher Copyright:
© 2019 American Chemical Society.
PY - 2019/6/13
Y1 - 2019/6/13
N2 - As the number of cases and cancer-related deaths are projected to rise in upcoming years, it is urgent to find ways to prevent or treat cancer. As such, food-derived products have gained attention as potential chemopreventive agents due to their availability, safety, and low cost. Isothiocyanates, the breakdown products of sulfur-containing glucosinolates in cruciferous vegetables, have shown substantial anticarcinogenic and chemopreventive activities for different human cancers. Furthermore, organoselenium compounds are known to exhibit chemopreventive and chemotherapeutic activity; moreover, these compounds are more effective anticancer agents than their sulfur isosteres. Hence, isothiocyanates have been modified to yield isoselenocyanates, which are more cytotoxic toward cancer cells when compared to their corresponding sulfur analogues. Herein, the synthesis and development of isoselenocyanates as novel treatments for cancer and other diseases are reviewed, highlighting the diverse chemistry and computational studies of this class of compounds as well as their pertinent biological applications.
AB - As the number of cases and cancer-related deaths are projected to rise in upcoming years, it is urgent to find ways to prevent or treat cancer. As such, food-derived products have gained attention as potential chemopreventive agents due to their availability, safety, and low cost. Isothiocyanates, the breakdown products of sulfur-containing glucosinolates in cruciferous vegetables, have shown substantial anticarcinogenic and chemopreventive activities for different human cancers. Furthermore, organoselenium compounds are known to exhibit chemopreventive and chemotherapeutic activity; moreover, these compounds are more effective anticancer agents than their sulfur isosteres. Hence, isothiocyanates have been modified to yield isoselenocyanates, which are more cytotoxic toward cancer cells when compared to their corresponding sulfur analogues. Herein, the synthesis and development of isoselenocyanates as novel treatments for cancer and other diseases are reviewed, highlighting the diverse chemistry and computational studies of this class of compounds as well as their pertinent biological applications.
UR - http://www.scopus.com/inward/record.url?scp=85060519005&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85060519005&partnerID=8YFLogxK
U2 - 10.1021/acs.jmedchem.8b01698
DO - 10.1021/acs.jmedchem.8b01698
M3 - Article
C2 - 30633510
AN - SCOPUS:85060519005
SN - 0022-2623
VL - 62
SP - 5261
EP - 5275
JO - Journal of Medicinal Chemistry
JF - Journal of Medicinal Chemistry
IS - 11
ER -